Avanos Medical, Inc. (AVNS)
NYSE: AVNS · IEX Real-Time Price · USD
19.73
+0.05 (0.25%)
May 6, 2024, 4:00 PM EDT - Market closed
Avanos Medical Revenue
Avanos Medical had revenue of $680.10M in the twelve months ending March 31, 2024, down -0.58% year-over-year. Revenue in the quarter ending March 31, 2024 was $166.10M with 4.27% year-over-year growth. In the year 2023, Avanos Medical had annual revenue of $673.30M, a decrease of -1.58%.
Revenue (ttm)
$680.10M
Revenue Growth
-0.58%
P/S Ratio
1.33
Revenue / Employee
$180,350
Employees
3,771
Market Cap
905.68M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 673.30M | -10.80M | -1.58% |
Dec 31, 2022 | 684.10M | 97.10M | 16.54% |
Dec 31, 2021 | 587.00M | -127.80M | -17.88% |
Dec 31, 2020 | 714.80M | 17.20M | 2.47% |
Dec 31, 2019 | 697.60M | 45.30M | 6.94% |
Dec 31, 2018 | 652.30M | 40.70M | 6.65% |
Dec 31, 2017 | 611.60M | 45.40M | 8.02% |
Dec 31, 2016 | 566.20M | 57.20M | 11.24% |
Dec 31, 2015 | 509.00M | -1.16B | -69.56% |
Dec 31, 2014 | 1.67B | -5.40M | -0.32% |
Dec 31, 2013 | 1.68B | -6.50M | -0.39% |
Dec 31, 2012 | 1.68B | 24.10M | 1.45% |
Dec 31, 2011 | 1.66B | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
OPKO Health | 863.50M |
Artivion | 354.00M |
BioCryst Pharmaceuticals | 331.41M |
Canopy Growth | 248.53M |
Paragon 28 | 216.39M |
Arcutis Biotherapeutics | 59.61M |
Relay Therapeutics | 35.33M |
Mesoblast | 7.25M |
AVNS News
- 4 days ago - Avanos Medical, Inc. Announces First Quarter 2024 Results - PRNewsWire
- 11 days ago - Avanos Medical, Inc. to Webcast Conference Call Discussing First Quarter 2024 Financial Results - PRNewsWire
- 2 months ago - Avanos Medical, Inc. Announces Voluntary Recall in Response to Nurse Assist, LLC Sterile Water Medical Products Recall - PRNewsWire
- 2 months ago - Avanos Medical, Inc. Announces Fourth Quarter and Full-Year 2023 Results - PRNewsWire
- 2 months ago - Avanos Medical, Inc. to Webcast Conference Call Discussing Fourth Quarter and Full Year 2023 Financial Results - PRNewsWire
- 2 months ago - INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Avanos Medical, Inc. and Encourages Investors with Losses to Contact the Firm - Accesswire
- 3 months ago - SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Avanos Medical, Inc. and Encourages Investors with Losses to Contact the Firm - Accesswire
- 3 months ago - IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against Avanos Medical, Inc. and Encourages Investors with Losses to Contact the Firm - Accesswire